Akeso Receives USD 250 Million to Boost Global Expansion of its Drug Pipeline
Seventy percent of the financing will accelerate the global clinical development of innovative drugs developed internally by Akeso, with a primary focus on its core products in both China and international markets.
Global Clinical Development | 14/10/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy